HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb - Wikidata - wikimedia - TriplyDB

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

http://www.wikidata.org/entity/Q34034551

about

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery Fiber-optic multiphoton flow cytometry in whole blood and in vivo.Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma.Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer.Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.Biomedical applications of trastuzumab: as a therapeutic agent and a targeting ligand.Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers.Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.Biocompatible Size-Defined Dendrimer-Albumin Binding Protein Hybrid Materials as a Versatile Platform for Biomedical Applications.Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.Dendrimers in combination with natural products and analogues as anti-cancer agents.Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.Novel advances in targeted drug delivery.HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells.

P2860

Q26825175-27F0219E-EED2-43EF-9B83-9CCA94C8CDAA Q33640942-07598256-E81F-47C7-AA04-A107A35BF34F Q34076929-BB1999E9-D13E-4A10-9BE0-27258E755123 Q35184402-D6AD8F99-9071-4195-AA82-0C7379B6F085 Q35624762-830B4D52-F56A-416F-A74C-F9C8B4269281 Q35688131-4929B36E-9E4F-44A2-869A-523FE8DC8E57 Q36191573-46069C59-0C30-4AB9-8709-7992EDAC64CB Q36774169-A8890C08-E656-4B8F-996B-95E6F2D3C481 Q37225532-664773C5-288F-48A7-AA46-FD2A5CA1251D Q37383231-5AF7EFCA-A08E-4DDC-96AD-C771C4CD74F2 Q37564495-1047EFB1-34E1-43B7-802D-4FB6B76E4887 Q37886750-AF0D4A4C-9359-4DEC-95F2-865144CD9CD3 Q38071913-5872460B-A712-40D1-80EE-B50626678611 Q38167284-F51E9ABA-88E2-4A1B-ACA1-AF9D399E49C1 Q38408138-F11BB9BA-AAA2-45E8-8176-4D07089E0541 Q38690866-AD89701B-1A34-4584-8139-F50413683DA1 Q38705194-B219E4D7-A467-4A9E-B108-D65ECC4820BE Q38805312-BA5C9F3D-2960-48B7-A6FD-906083AD3370 Q39158035-69E22CBE-D644-49CA-9180-CF6DAD3D3556 Q41104930-71FAFAB7-F580-4354-B01F-9953F12F8D21 Q47333126-6F543B60-586D-437D-9A3B-97E97B55BCBE Q50002187-828BB8F9-0DAC-49C9-9EAB-AA23EB51A26A Q50220612-ACF4D37A-3D70-472A-9DAA-5285DC544D3F Q52725211-4EAF1CE0-A394-42CA-A6D3-32C5FAA780F4

P2860

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

http://www.wikidata.org/entity/Q34034551

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@ast

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@en

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@nl

type

label

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@ast

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@en

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@nl

prefLabel

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@ast

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@en

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@nl

P1433

Q34034551-05857F95-26B6-49B4-BE3E-4737B4FB86C5

P1476

Q34034551-18E93B20-132B-44A4-9367-6065A7FBAB40

P2093

Q34034551-28DEFCFF-DA03-44DE-9DDD-13C352EC9098

Q34034551-7245DFEF-3839-4D8B-819C-35D802BEEA70

Q34034551-7E14DC57-C083-4CEE-BEDE-9D27AC08A0DE

Q34034551-A6264A8D-B919-44D3-9CB5-7BEF5B711352

Q34034551-BC11ACE6-7C73-4372-8E35-4DB079F00F32

Q34034551-CB8099D7-B74F-4765-8394-8F38C7E17308

P2860

Q34034551-3694F476-4C66-49D3-A6DE-A2B9CAFA8959

Q34034551-36B8269C-5A8E-4306-94DD-069D43B2CCA0

Q34034551-424333EE-42E0-4006-8FEB-A4A7D3E28AE6

Q34034551-4F732B40-0217-432E-A233-B6674D2BBB82

Q34034551-6B6A99DA-E324-4F9F-8374-16FCFF5AEFD8

Q34034551-7D99C5A6-2D2A-4773-9F20-CA75DA10F0A8

Q34034551-824D13E5-1C8B-435D-8849-DE43085839AA

Q34034551-8EEC0E26-F2B8-4FFD-81E9-421276058BED

Q34034551-92C369F2-F654-40FB-91EE-B1A42A7E1C70

Q34034551-9B1F0698-E62B-4941-9C1B-F4990645C451

P304

Q34034551-B4266B44-C4E2-4D00-86CF-C512637CDA70

P31

Q34034551-F04929CD-AFAA-4A5E-A4DF-63A0DDD135B0

P356

Q34034551-E2D7E9B7-B501-4A24-8E00-2A44ABFE645B

P433

Q34034551-BFC939A1-6FAF-4A87-9E13-E68ADE7C89E6

P478

Q34034551-947CFCEB-E636-44B0-A255-E14F2B1B0B7C

P577

Q34034551-E4EC08E5-1D6C-423A-9D28-E370B23167BC

P5875

Q34034551-0CE734B9-0D76-4CEE-B1C8-6DF434C32876

P698

Q34034551-C8997DC6-B41E-4A84-ADB6-5ED03484FE34

P932

Q34034551-EB4FF30F-C430-49A1-AC23-9331ECEA2D04

P356

P1433

P1476

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

@en

P2093

Alina Kotlyar

http://www.w3.org/2001/XMLSchema#string

Ankur M Desai

http://www.w3.org/2001/XMLSchema#string

James R Baker

http://www.w3.org/2001/XMLSchema#string

Rameshwer Shukla

http://www.w3.org/2001/XMLSchema#string

Steve J Park

http://www.w3.org/2001/XMLSchema#string

Thommey P Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

The ErbB signaling network: receptor heterodimerization in development and cancer

Detection and analysis of tumor fluorescence using a two-photon optical fiber probe.

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery.

Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro.

P304

295102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1088/0957-4484/19/29/295102

http://www.w3.org/2001/XMLSchema#string

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45506039

http://www.w3.org/2001/XMLSchema#string

P698

20686639

http://www.w3.org/2001/XMLSchema#string

P932

2913620

http://www.w3.org/2001/XMLSchema#string